Ronald Scott becomes chief operating officer of Basilea
Formerly held role of chief financial officer
Scott was appointed chief financial officer at the company's inception in 2000. In addition to finance, business development, investor relations and public relations, he has taken responsibility for commercial activities, manufacturing and corporate services.
Basilea’s chief executive, Anthony Man, commented: ‘Ron has demonstrated his management skills in finance and business development as attested by Basilea's significant transactions achieved under his leadership.
‘This change allows me to focus on our highest business priorities associated with Toctino, ceftobiprole, isavuconazole together with our new Gram-negative antibiotic and anti-cancer drug development as well as on our mid-to-long term strategy to build value through r&d innovation.’
